After our recent meeting at the Pharmaceutical Contract Management Group about site payments, it’s helpful to further explore the impact of integrating electronic data capture with payments technology.
On November 30, Medidata will once again have the privilege of joining hundreds of industry movers and shakers at the prestigious Scrip Awards in London. Now in its 12th year, the Scrip Awards recognize both organizations and individuals who are driving meaningful change across the life sciences—from pioneering research to next-generation clinical trial tools.
Yet, better therapies aren’t the product of a single person, nor of a single research team, program or company.
Medidata's Global Lead on Payments, Marcus Thornton, and Managing Director April Mulroney recently spoke at the Pharmaceutical Contract Management Group (PCMG) conference in Basel, Switzerland. Below, Marcus reflects on the site payments session, which featured pain points and best practices articulated by industry decision makers.
Recent findings from Medidata Trial Assurance highlight the power of machine learning algorithms and their impact on pharmaceutical companies seeking greater capabilities to ensure data quality.